The power and pitfalls of using social media to study rare cancers

Abstract

This news section is written by a medical journalist and offers Cancer Cytopathology readers timely information on events, issues, and personalities of interest to the subspecialty. This issue covers how Facebook, X, and other platforms can aid patient education and recruitment efforts in studying rare cancers.